Results 241 to 250 of about 737,165 (295)

Combining antibody conjugates with cytotoxic and immune‐stimulating payloads maximizes anti‐cancer activity

open access: yesMolecular Oncology, EarlyView.
Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang   +3 more
wiley   +1 more source

Loss of intracellular ATP affects axoplasmic viscosity and pathological protein aggregation in mammalian neurons. [PDF]

open access: yesSci Adv
Guillaud L   +6 more
europepmc   +1 more source

Induction of hepatitis B core protein aggregation targeting an unconventional binding site. [PDF]

open access: yesElife
Khayenko V   +6 more
europepmc   +1 more source

Co-translational protein aggregation and ribosome stalling as a broad-spectrum antibacterial mechanism. [PDF]

open access: yesNat Commun
Khodaparast L   +16 more
europepmc   +1 more source

Increased activity of PRMT5-MEP50 complex improves survival of chromosomally unstable cancer cells by increasing tolerance to protein aggregation and proteotoxicity

open access: yes
Suarez Peredo Rodriguez MF   +14 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Protein Aggregation

Clinical Chemistry and Laboratory Medicine, 2001
Protein aggregation occurs in vivo as a result of improper folding or misfolding. Diverse diseases arise from protein misfolding and are now grouped under the term "protein conformational diseases", including most of the neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease, the prion encephalopathies and Huntington's disease, as
MERLINI, GIAMPAOLO   +6 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy